GlassScriptPhysician profile
Ramon P Dizon
NPI 1619940715
$661.27
in general payments reported to CMS, 2019-2025
7 companies · $407 in 2025
The $407 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.24 · 2024: $238 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597 · Education: $48.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.53 |
| Education | $48.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $134.48 | 2024-2025 | |
| Shionogi INC | $130.30 | 2024-2025 | Fetroja |
| Merck Sharp & Dohme LLC | $122.47 | 2024-2025 | Zerbaxa, Pifeltro, Capvaxive |
| Viiv Healthcare Company | $115.69 | 2025 | Dovato, Cabenuva |
| Insmed, INC. | $81.39 | 2022-2025 | Arikayce |
| Aimmune Therapeutics, INC. | $50.26 | 2024-2025 | Vowst |
| Pfizer INC. | $26.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Dizon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.